Mirae Asset Global ETFs Holdings
CERE

Mirae Asset Global ETFs Holdings’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-42,761
Closed -$1.75M – 3244
2024
Q2 		$1.75M Buy
+42,761
New +$1.78M ﹤0.01% 1140

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CERE Position: Q3 2024 in Review

Mirae Asset Global ETFs Holdings sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 42,761 shares — an estimated $1.75M sold.

Mirae Asset Global ETFs Holdings first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $1.75M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Mirae Asset Global ETFs Holdings reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 42,761 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.75M.
  • Mirae Asset Global ETFs Holdings first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Mirae Asset Global ETFs Holdings's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.75M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.